drugset / Trial / NCT01125527
Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children
RandomizedParallel-groupSingle-blindPrevention
Summary
This study will evaluate the safety and immunogenicity of single dose of two commercially available vaccines used to prevent Haemophilus influenzae type b infections in children 13-59 months of age.
Timeline
- Start
- 2009-08
- Primary completion
- 2009-10
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib) | Vaccine | — | — |
| Comparator | Tetanus toxoid polysaccharide-conjugated vaccine against Haemophilus influenzae type b (Hib) | Vaccine | — | — |